@article{lewis.etal_2019a,
  title = {Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension},
  author = {Lewis, R.E. and Kontoyiannis, D.P. and Viale, P. and Sarpong, E.M.},
  year = {2019},
  journal = {Antimicrobial Agents and Chemotherapy},
  volume = {63},
  number = {12},
  doi = {10.1128/AAC.01435-19},
  note = {Cited By :7
\par
Cited By :7
\par
Export Date: 20 November 2022
\par
Export Date: 20 November 2022},
  file = {/Users/russelllewis/Zotero/storage/5DE5NALL/Lewis et al_2019_Using state transition models to explore how the prevalence of subtherapeutic.pdf}
}

{"_id":"gaXAmzQ8R8eb75BCr","bibbaseid":"lewis-kontoyiannis-viale-sarpong-usingstatetransitionmodelstoexplorehowtheprevalenceofsubtherapeuticposaconazoleexposuresimpactstheclinicalutilityoftherapeuticdrugmonitoringforposaconazoletabletsandoralsuspension-2019","author_short":["Lewis, R.","Kontoyiannis, D.","Viale, P.","Sarpong, E."],"bibdata":{"bibtype":"article","type":"article","title":"Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension","author":[{"propositions":[],"lastnames":["Lewis"],"firstnames":["R.E."],"suffixes":[]},{"propositions":[],"lastnames":["Kontoyiannis"],"firstnames":["D.P."],"suffixes":[]},{"propositions":[],"lastnames":["Viale"],"firstnames":["P."],"suffixes":[]},{"propositions":[],"lastnames":["Sarpong"],"firstnames":["E.M."],"suffixes":[]}],"year":"2019","journal":"Antimicrobial Agents and Chemotherapy","volume":"63","number":"12","doi":"10.1128/AAC.01435-19","note":"Cited By :7 \\par Cited By :7 \\par Export Date: 20 November 2022 \\par Export Date: 20 November 2022","file":"/Users/russelllewis/Zotero/storage/5DE5NALL/Lewis et al_2019_Using state transition models to explore how the prevalence of subtherapeutic.pdf","bibtex":"@article{lewis.etal_2019a,\n title = {Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension},\n author = {Lewis, R.E. and Kontoyiannis, D.P. and Viale, P. and Sarpong, E.M.},\n year = {2019},\n journal = {Antimicrobial Agents and Chemotherapy},\n volume = {63},\n number = {12},\n doi = {10.1128/AAC.01435-19},\n note = {Cited By :7\n\\par\nCited By :7\n\\par\nExport Date: 20 November 2022\n\\par\nExport Date: 20 November 2022},\n file = {/Users/russelllewis/Zotero/storage/5DE5NALL/Lewis et al_2019_Using state transition models to explore how the prevalence of subtherapeutic.pdf}\n}\n\n","author_short":["Lewis, R.","Kontoyiannis, D.","Viale, P.","Sarpong, E."],"key":"lewis.etal_2019a","id":"lewis.etal_2019a","bibbaseid":"lewis-kontoyiannis-viale-sarpong-usingstatetransitionmodelstoexplorehowtheprevalenceofsubtherapeuticposaconazoleexposuresimpactstheclinicalutilityoftherapeuticdrugmonitoringforposaconazoletabletsandoralsuspension-2019","role":"author","urls":{},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/a6GBPjh3wXfA46RXX/CV.bib","dataSources":["jKN7prtxaY9N8vqst","qLqjc4bwMYLmk2F3c","8E62bsJiEchQrmW6z"],"keywords":[],"search_terms":["using","state","transition","models","explore","prevalence","subtherapeutic","posaconazole","exposures","impacts","clinical","utility","therapeutic","drug","monitoring","posaconazole","tablets","oral","suspension","lewis","kontoyiannis","viale","sarpong"],"title":"Using State Transition Models to Explore How the Prevalence of Subtherapeutic Posaconazole Exposures Impacts the Clinical Utility of Therapeutic Drug Monitoring for Posaconazole Tablets and Oral Suspension","year":2019}